Multi-Center Clinical Evaluation of Two Daily Disposable Contact Lenses

Sponsor
Alcon Research (Industry)
Overall Status
Completed
CT.gov ID
NCT01898260
Collaborator
(none)
89
1
2
2
44.4

Study Details

Study Description

Brief Summary

The purpose of this study is to compare the subjective performance of two daily disposable contact lenses with respect to comfort and handling.

Condition or Disease Intervention/Treatment Phase
  • Device: Ultrafilcon B contact lens
  • Device: Stenfilcon A contact lens
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
89 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Double (Participant, Investigator)
Official Title:
Multi-Center Clinical Evaluation of Two Daily Disposable Contact Lenses
Study Start Date :
Aug 1, 2013
Actual Primary Completion Date :
Oct 1, 2013
Actual Study Completion Date :
Oct 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Other: BYO Daily, then MyDay

Ultrafilcon B contact lenses, followed by stenfilcon A contact lenses. Each product worn bilaterally for 1 week in a daily wear, daily disposable modality.

Device: Ultrafilcon B contact lens
Silicone hydrogel contact lens CE-marked for daily disposable wear. Private-label versions may be used.
Other Names:
  • Procornea BYO™ Air Daily
  • Device: Stenfilcon A contact lens
    Silicone hydrogel contact lens CE-marked for daily disposable wear. Private-label versions may be used.
    Other Names:
  • MyDay™ Daily Disposable
  • Other: MyDay, then BYO Daily

    Stenfilcon A contact lenses, followed by ultrafilcon B contact lenses. Each product worn bilaterally for 1 week in a daily wear, daily disposable modality.

    Device: Ultrafilcon B contact lens
    Silicone hydrogel contact lens CE-marked for daily disposable wear. Private-label versions may be used.
    Other Names:
  • Procornea BYO™ Air Daily
  • Device: Stenfilcon A contact lens
    Silicone hydrogel contact lens CE-marked for daily disposable wear. Private-label versions may be used.
    Other Names:
  • MyDay™ Daily Disposable
  • Outcome Measures

    Primary Outcome Measures

    1. Initial Comfort [Baseline]

      Initial Comfort will be assessed bilaterally by the participant at time of dispense. Initial Comfort will be graded on a 1-10 scale (10=cannot be felt, 1=painful).

    Secondary Outcome Measures

    1. End of Day Comfort [Day 7]

      End of Day Comfort will be assessed by the participant as a retrospective, bilateral evaluation of 1 week of wear. End of Day Comfort will be graded on a 1-10 scale (10=cannot be felt, 1=painful).

    2. Overall Comfort [Day 7]

      Overall Comfort will be assessed by the participant as a retrospective, bilateral evaluation of 1 week of wear. Overall Comfort will be graded on a 1-10 scale (10=cannot be felt, 1=painful).

    3. Overall Handling at Time of Removal [Day 7]

      Overall Handling at Time of Removal will be assessed by the participant as a retrospective, bilateral evaluation of 1 week of wear. Overall Handling at Time of Removal will be graded on a 1-10 scale (10=excellent, very easy; 1=unmanageable).

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 45 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Adapted soft contact lens wearer;

    • Spherical distance contact lens prescription between -1.00 and -6.00 diopter (inclusive);

    • Spectacle cylinder ≤0.75 diopter in the least astigmatic eye, ≤1.00 diopter in the other;

    • Correctable to 6/9 (20/30) in both eyes;

    • Read, understood and signed the informed consent;

    • Willing to comply with the wear schedule;

    • Willing to comply with the study visit schedule;

    • Other protocol-defined inclusion criteria may apply.

    Exclusion Criteria:
    • Any active corneal infection, injury or inflammation;

    • Systemic or ocular allergies which might interfere with contact lens wear;

    • Systemic or ocular disease which might interfere with contact lens wear;

    • Strabismus or amblyopia;

    • Corneal refractive surgery and any anterior segment surgery;

    • Use of systemic/topical medication contraindicating contact lens wear;

    • Use of gas permeable contact lenses within 1 month preceding the study;

    • Participation in any concurrent clinical trial or in the last 30 days;

    • Other protocol-defined exclusion criteria may apply.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Alcon Investigative Site Surrey United Kingdom

    Sponsors and Collaborators

    • Alcon Research

    Investigators

    • Study Director: Joachim Nick, Dipl. Ing., Alcon Research

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Alcon Research
    ClinicalTrials.gov Identifier:
    NCT01898260
    Other Study ID Numbers:
    • C-13-032
    First Posted:
    Jul 12, 2013
    Last Update Posted:
    May 12, 2015
    Last Verified:
    Oct 1, 2014
    Keywords provided by Alcon Research
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 12, 2015